Ross\Johnson & Associates’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113 Buy
+1
New +$99 ﹤0.01% 288
2025
Q2
Sell
-14
Closed -$848 278
2025
Q1
$848 Buy
+14
New +$976 0.01% 219

Other funds holding INCY

Ross\Johnson & Associates's INCY Position: Q2 2026 in Review

Ross\Johnson & Associates opened a new position in Incyte (INCY) in Q2 2026: 1 share worth $113. The stake represents ﹤0.01% of the portfolio and ranks #288 among its holdings. This is a return to the name: Ross\Johnson & Associates previously reported a position in INCY as recently as Q1 2025.

Ross\Johnson & Associates first reported a position in INCY in Q1 2025 and has held it in 2 quarters since. The position peaked at $848 in Q1 2025. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Ross\Johnson & Associates held 1 share of Incyte worth $113 as of Q2 2026.
  • Incyte was a new Ross\Johnson & Associates position in Q2 2026.
  • Incyte made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #288 holding.
  • Ross\Johnson & Associates first reported a position in Incyte in Q1 2025 and has held it in 2 quarters since.
  • Ross\Johnson & Associates's Incyte position peaked at $848 in Q1 2025.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.